New drug for restless legs syndrome: efficacy and safety study
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with restless legs syndrome (RLS) by a doctor, including common or unusual forms.
- Your RLS symptoms are moderate to severe (a score of 11 or higher on a standard RLS rating scale).
- You do not have RLS caused by another condition (like severe iron deficiency, kidney problems, pregnancy, or certain drugs).
- You are not pregnant or breastfeeding, and you do not have serious heart, liver, kidney, or active mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a small implanted device that sends electrical signals to the spinal cord can help people with severe restless leg syndrome (RLS) who haven't improved with medications. RLS causes uncomfortable sensations in the legs, especially at night, and this treatment may provide relief when standard drugs don't work.
This study tests whether a device that sends mild electrical pulses to the spinal cord can reduce the symptoms of restless legs syndrome (RLS) in people who have not gotten enough relief from medications. If successful, it could offer a new treatment option for severe RLS.
This study tests whether a spinal cord stimulator can help people with restless leg syndrome (RLS). It compares people with RLS to healthy volunteers to see if the device reduces symptoms.
This study tests whether cannabis can help people with Restless Legs Syndrome that has not improved with standard treatments. If you have RLS and other treatments haven't worked well, you may be able to join.
This trial tests if using a special light (near-infrared) and gentle vibration can help relieve restless leg syndrome in people with type 2 diabetes. If you have uncomfortable leg feelings that get worse when resting and better when moving, this study may offer a new way to find relief.
This trial tests if a small nerve stimulation device can safely and effectively reduce restless legs symptoms in pregnant people. If you are between 21 and 26 weeks pregnant with a confirmed diagnosis of restless legs syndrome (RLS), you may be eligible.
Hear when a new Restless Leg Syndrome (RLS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.